Critical Care Nephrology – Research Article

Zhang R.a,b· Tian C.a,b· Cai S.a,b· Ma J.a,b· Li J.a,b· Li Z.a,b· You J.a,b· Ding X.a,b· Peng Z.a,b

Author affiliations

aDepartment of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China
bHubei Clinical Research Center for Critical Care Medicine, Wuhan, China

Log in to MyKarger to check if you already have access to this content.

Buy FullText & PDF Unlimited re-access via MyKarger Unrestricted printing, no saving restrictions for personal use read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Access via DeepDyve Unlimited fulltext viewing Of this article Organize, annotate And mark up articles Printing And downloading restrictions apply

Select

Subscribe Access to all articles of the subscribed year(s) guaranteed for 5 years Unlimited re-access via Subscriber Login or MyKarger Unrestricted printing, no saving restrictions for personal use read more

Subcription rates

Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview

Received: April 04, 2022
Accepted: June 27, 2022
Published online: July 27, 2022

Number of Print Pages: 8
Number of Figures: 3
Number of Tables: 2

ISSN: 0253-5068 (Print)
eISSN: 1421-9735 (Online)

For additional information: https://www.karger.com/BPU

Abstract

Background: Low-flow extracorporeal carbon dioxide removal (LF-ECCO2R) has the potential to play an important role in the management of adults with acute respiratory failure. However, it has never been tested in China. The study aimed at exploring the safety and efficacy on LF-ECCO2R for acute respiratory failure in a Chinese tertiary intensive care unit (ICU). Materials and Methods: We performed a retrospective case note review of patients admitted to our tertiary regional ICU and commenced on LF-ECCO2R from June 2020 to September 2021. The LF-ECCO2R device we used was ProLUNG® system (Estor S.p.A., Milan, Italy). The device employed a nonporous poly-4-methyl-1-pentene membrane lung with a surface area of 1.81 m2 and run at an extracorporeal blood flow between 100 and 450 mL/min. Demographic and physiologic data (including ventilation parameters and arterial blood gases) as well as the outcome of LF-ECCO2R treatment were recorded. Results: A total of 12 cases were included. A statistically significant reduction in respiratory rate, driving pressure, PaCO2, and blood lactate was observed. In addition, there was a statistically significant improvement in pH and PaO2/FiO2. Six out of 12 patients (50%) were discharged alive from ICU. Three complications related to LF-ECCO2R were reported, none resulting in serious adverse outcomes. Conclusion: Our clinical series indicated that LF-ECCO2R seemed to be safely applied in patients with acute respiratory failure. The efficacy of CO2 removal as well as the improved respiratory parameters was also observed. However, large-scale randomized clinical trials are needed to confirm the effects.

© 2022 S. Karger AG, Basel

References Kolobow T, Gattinoni L, Tomlinson TA, Pierce JE. Control of breathing using an extracorporeal membrane lung. Anesthesiology. 1977;46(2):138–41. Loeppky JA, Luft UC, Fletcher ER. Quantitative description of whole blood CO2 dissociation curve and Haldane effect. Respir Physiol. 1983;51(2):167–81. Duscio E, Cipulli F, Vasques F, Collino F, Rapetti F, Romitti F, et al. Extracorporeal CO2 removal: the minimally invasive approach, theory, and practice. Crit Care Med. 2019;47(1):33–40. Grasselli G, Castagna L, Bottino N, Scaravilli V, Corcione N, Guzzardella A, et al. Practical clinical application of an extracorporeal carbon dioxide removal system in acute respiratory distress syndrome and acute on chronic respiratory failure. ASAIO J. 2020;66(6):691–7. Pisani L, Fasano L, Corcione N, Comellini V, Guerrieri A, Ranieri MV, et al. Effects of extracorporeal CO2 removal on inspiratory effort and respiratory pattern in patients who fail weaning from mechanical ventilation. Am J Respir Crit Care Med. 2015;192(11):1392–4. Ruberto F, Bergantino B, Testa MC, D’Arena C, Bernardinetti M, Diso D, et al. Low-flow veno-venous extracorporeal CO2 removal: first clinical experience in lung transplant recipients. Int J Artif Organs. 2014;37(12):911–7. Acute Respiratory Distress Syndrome Network; Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342(18):1301–8. Amato MB, Meade MO, Slutsky AS, Brochard L, Costa EL, Schoenfeld DA, et al. Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med. 2015;372(8):747–55. Villar J, Blanco J, Añón JM, Santos-Bouza A, Blanch L, Ambrós A, et al. The ALIEN study: incidence and outcome of acute respiratory distress syndrome in the era of lung protective ventilation. Intensive Care Med. 2011;37(12):1932–41. Fanelli V, Ranieri MV, Mancebo J, Moerer O, Quintel M, Morley S, et al. Feasibility and safety of low-flow extracorporeal carbon dioxide removal to facilitate ultra-protective ventilation in patients with moderate acute respiratory distress syndrome. Crit Care. 2016;20(1):36. Wedzicha JA, Miravitlles M, Hurst JR, Calverley PM, Albert RK, Anzueto A, et al. Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline. Eur Respir J. 2017;49(3):1600791. Chandra D, Stamm JA, Taylor B, Ramos RM, Satterwhite L, Krishnan JA, et al. Outcomes of noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease in the United States, 1998–2008. Am J Respir Crit Care Med. 2012;185(2):152–9. Stefan MS, Nathanson BH, Higgins TL, Steingrub JS, Lagu T, Rothberg MB, et al. Comparative effectiveness of noninvasive and invasive ventilation in critically ill patients with acute exacerbation of chronic obstructive pulmonary disease. Crit Care Med. 2015;43(7):1386–94. Burki NK, Mani RK, Herth FJF, Schmidt W, Teschler H, Bonin F, et al. A novel extracorporeal CO(2) removal system: results of a pilot study of hypercapnic respiratory failure in patients with COPD. Chest. 2013;143(3):678–86. Kluge S, Braune SA, Engel M, Nierhaus A, Frings D, Ebelt H, et al. Avoiding invasive mechanical ventilation by extracorporeal carbon dioxide removal in patients failing noninvasive ventilation. Intensive Care Med. 2012;38(10):1632–9. Camporota L, Barrett N. Current applications for the use of extracorporeal carbon dioxide removal in critically ill patients. Biomed Res Int. 2016;2016:9781695. Morelli A, Del Sorbo L, Pesenti A, Ranieri VM, Fan E. Extracorporeal carbon dioxide removal (ECCO(2)R) in patients with acute respiratory failure. Intensive Care Med. 2017;43(4):519–30. Combes A, Schmidt M, Hodgson CL, Fan E, Ferguson ND, Fraser JF, et al. Extracorporeal life support for adults with acute respiratory distress syndrome. Intensive Care Med. 2020;46(12):2464–76. Azzi M, Aboab J, Alviset S, Ushmorova D, Ferreira L, Ioos V, et al. Extracorporeal CO(2) removal in acute exacerbation of COPD unresponsive to non-invasive ventilation. BMJ Open Respir Res. 2021;8(1):e001089. Giraud R, Banfi C, Assouline B, De Charrière A, Cecconi M, Bendjelid K. The use of extracorporeal CO(2) removal in acute respiratory failure. Ann Intensive Care. 2021;11(1):43. Di Nardo M, Vercaemst L, Swol J, Barret N, Taccone FS, Malfertheiner MV, et al. A narrative review of the technical standards for extracorporeal life support devices (pumps and oxygenators) in Europe. Perfusion. 2018;33(7):553–61. De Rosa S, Golino G, Ronco C. Extracorporeal carbon dioxide removal in heart-beating donor with acute severe asthma: a case report. Respir Med Case Rep. 2020;29:101010. Morales-Quinteros L, Del Sorbo L, Artigas A. Extracorporeal carbon dioxide removal for acute hypercapnic respiratory failure. Ann Intensive Care. 2019;9(1):79. Combes A, Auzinger G, Capellier G, du Cheyron D, Clement I, Consales G, et al. ECCO(2)R therapy in the ICU: consensus of a European round table meeting. Crit Care. 2020;24(1):490. Staudinger T. Update on extracorporeal carbon dioxide removal: a comprehensive review on principles, indications, efficiency, and complications. Perfusion. 2020;35(6):492–508. Yu TZ, Tatum RT, Saxena A, Ahmad D, Yost CC, Maynes EJ, et al. Utilization and outcomes of extracorporeal CO(2) removal (ECCO(2)R): systematic review and meta-analysis of arterio-venous and veno-venous ECCO(2) R approaches. Artif Organs. 2022;46(5):763–74. Fitzgerald M, Millar J, Blackwood B, Davies A, Brett SJ, McAuley DF, et al. Extracorporeal carbon dioxide removal for patients with acute respiratory failure secondary to the acute respiratory distress syndrome: a systematic review. Crit Care. 2014;18(3):222. Augy JL, Aissaoui N, Richard C, Maury E, Fartoukh M, Mekontso-Dessap A, et al. A 2-year multicenter, observational, prospective, cohort study on extracorporeal CO(2) removal in a large metropolis area. J Intensive Care. 2019;7(1):45. Article / Publication Details

First-Page Preview

Received: April 04, 2022
Accepted: June 27, 2022
Published online: July 27, 2022

Number of Print Pages: 8
Number of Figures: 3
Number of Tables: 2

ISSN: 0253-5068 (Print)
eISSN: 1421-9735 (Online)

For additional information: https://www.karger.com/BPU

Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.